基于益生元的阿莫西林口服制剂的胃保护功效

IF 2.7 4区 医学 Q2 PHARMACOLOGY & PHARMACY
Shashi Supriya, Vineet Kumar Rai, Deepak Pradhan, Jitu Halder, Tushar Kanti Rajwar, Ritu Mahanty, Ivy Saha, Priyanka Dash, Chandan Dash, Saroj Kumar Rout, Jameel Al-Tamimi, Hossan Ebaid, Salim Manoharadas, Biswakanth Kar, Goutam Ghosh, Goutam Rath
{"title":"基于益生元的阿莫西林口服制剂的胃保护功效","authors":"Shashi Supriya,&nbsp;Vineet Kumar Rai,&nbsp;Deepak Pradhan,&nbsp;Jitu Halder,&nbsp;Tushar Kanti Rajwar,&nbsp;Ritu Mahanty,&nbsp;Ivy Saha,&nbsp;Priyanka Dash,&nbsp;Chandan Dash,&nbsp;Saroj Kumar Rout,&nbsp;Jameel Al-Tamimi,&nbsp;Hossan Ebaid,&nbsp;Salim Manoharadas,&nbsp;Biswakanth Kar,&nbsp;Goutam Ghosh,&nbsp;Goutam Rath","doi":"10.1007/s12247-024-09875-1","DOIUrl":null,"url":null,"abstract":"<div><h3>Purpose</h3><p>Amoxicillin's side effects are due to its propensity to disturb gut flora. Prebiotics can aid in reversing the dysbiosis caused by antibiotics by promoting the growth of various indigenous gut flora. The present investigation aims to determine the prebiotic potential of common binders (starch, gelatin, pectin, and guar gum) against <i>L. acidophilus</i>. The further objective is to explore the potential biological advantages of amoxicillin therapy when prepared with potential prebiotic excipients.</p><h3>Methods</h3><p>In the current investigation, prebiotic-based amoxicillin granules were prepared by wet granulation method with 81.5 ± 3.26% yield. To ensure their therapeutic outcomes, prepared granules were evaluated based on drug release profile, drug degradation, prebiotic potential, in vitro antimicrobial activity, antioxidant activity, anti-inflammatory activity, and anti-diarrhoeal potential.</p><h3>Results</h3><p>After 24, 36, 48 and 60 h of incubation of <i>L. acidophilus</i> in different base materials, it was found that the growth of <i>L. acidophilus</i> was more in pectin, among other binders. Formulated granules showed better intestinal stability and sustained release profile (~ 60% release in 4 h). FTIR, DSC and XRD analyses revealed minimal interaction between the drug and the selected excipients. Granules were found to have superior <i>S. aureus</i> and <i>P. aeruginosa</i> inhibition potential compared with the pure drug and starch formulations. Also, the highest antioxidant activity was observed in the Pectin granules compared to starch granules and the pure drug. IL-6, IL1β, and TNF-α levels of the pectin-treated group show better anti-inflammatory properties than starch formulations and pure drugs. The anti-diarrhoeal effect of pectin was found to be better because it supports the growth of probiotics.</p><h3>Conclusion</h3><p>In this study, pectin-based amoxicillin granules were superior in mitigating the gastric distress associated with oral amoxicillin administration. The metabolites of probiotics reduced gut pathogens, inflammation, and oxidation, suggesting that the formulated pectin-amoxicillin granules effectively provide gastroprotection.</p><h3>Graphical Abstract</h3>\n<div><figure><div><div><picture><source><img></source></picture></div></div></figure></div></div>","PeriodicalId":656,"journal":{"name":"Journal of Pharmaceutical Innovation","volume":null,"pages":null},"PeriodicalIF":2.7000,"publicationDate":"2024-10-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Gastroprotective Efficacy of Prebiotic-based Oral Formulation of Amoxicillin\",\"authors\":\"Shashi Supriya,&nbsp;Vineet Kumar Rai,&nbsp;Deepak Pradhan,&nbsp;Jitu Halder,&nbsp;Tushar Kanti Rajwar,&nbsp;Ritu Mahanty,&nbsp;Ivy Saha,&nbsp;Priyanka Dash,&nbsp;Chandan Dash,&nbsp;Saroj Kumar Rout,&nbsp;Jameel Al-Tamimi,&nbsp;Hossan Ebaid,&nbsp;Salim Manoharadas,&nbsp;Biswakanth Kar,&nbsp;Goutam Ghosh,&nbsp;Goutam Rath\",\"doi\":\"10.1007/s12247-024-09875-1\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Purpose</h3><p>Amoxicillin's side effects are due to its propensity to disturb gut flora. Prebiotics can aid in reversing the dysbiosis caused by antibiotics by promoting the growth of various indigenous gut flora. The present investigation aims to determine the prebiotic potential of common binders (starch, gelatin, pectin, and guar gum) against <i>L. acidophilus</i>. The further objective is to explore the potential biological advantages of amoxicillin therapy when prepared with potential prebiotic excipients.</p><h3>Methods</h3><p>In the current investigation, prebiotic-based amoxicillin granules were prepared by wet granulation method with 81.5 ± 3.26% yield. To ensure their therapeutic outcomes, prepared granules were evaluated based on drug release profile, drug degradation, prebiotic potential, in vitro antimicrobial activity, antioxidant activity, anti-inflammatory activity, and anti-diarrhoeal potential.</p><h3>Results</h3><p>After 24, 36, 48 and 60 h of incubation of <i>L. acidophilus</i> in different base materials, it was found that the growth of <i>L. acidophilus</i> was more in pectin, among other binders. Formulated granules showed better intestinal stability and sustained release profile (~ 60% release in 4 h). FTIR, DSC and XRD analyses revealed minimal interaction between the drug and the selected excipients. Granules were found to have superior <i>S. aureus</i> and <i>P. aeruginosa</i> inhibition potential compared with the pure drug and starch formulations. Also, the highest antioxidant activity was observed in the Pectin granules compared to starch granules and the pure drug. IL-6, IL1β, and TNF-α levels of the pectin-treated group show better anti-inflammatory properties than starch formulations and pure drugs. The anti-diarrhoeal effect of pectin was found to be better because it supports the growth of probiotics.</p><h3>Conclusion</h3><p>In this study, pectin-based amoxicillin granules were superior in mitigating the gastric distress associated with oral amoxicillin administration. The metabolites of probiotics reduced gut pathogens, inflammation, and oxidation, suggesting that the formulated pectin-amoxicillin granules effectively provide gastroprotection.</p><h3>Graphical Abstract</h3>\\n<div><figure><div><div><picture><source><img></source></picture></div></div></figure></div></div>\",\"PeriodicalId\":656,\"journal\":{\"name\":\"Journal of Pharmaceutical Innovation\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":2.7000,\"publicationDate\":\"2024-10-19\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Pharmaceutical Innovation\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://link.springer.com/article/10.1007/s12247-024-09875-1\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Pharmaceutical Innovation","FirstCategoryId":"3","ListUrlMain":"https://link.springer.com/article/10.1007/s12247-024-09875-1","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

摘要

目的 阿莫西林的副作用是由于其扰乱肠道菌群的倾向。益生元可以通过促进各种本地肠道菌群的生长,帮助逆转抗生素造成的菌群失调。本研究旨在确定常见粘合剂(淀粉、明胶、果胶和瓜尔胶)对嗜酸乳杆菌的益生潜能。本研究采用湿法制粒法制备了基于益生元的阿莫西林颗粒,收率为 81.5 ± 3.26%。结果嗜酸乳杆菌在不同基质中培养 24、36、48 和 60 小时后发现,在果胶等粘合剂中,嗜酸乳杆菌的生长速度更快。配制的颗粒显示出更好的肠道稳定性和持续释放特性(4 小时内释放约 60%)。傅立叶变换红外光谱(FTIR)、二沉扫描电镜(DSC)和X射线衍射(XRD)分析表明,药物与所选辅料之间的相互作用极小。与纯药物和淀粉制剂相比,颗粒剂对金黄色葡萄球菌和铜绿假单胞菌的抑制潜力更强。此外,与淀粉颗粒和纯药物相比,果胶颗粒的抗氧化活性最高。果胶处理组的 IL-6、IL1β 和 TNF-α 水平显示出比淀粉制剂和纯药物更好的抗炎特性。结论 在本研究中,果胶基阿莫西林颗粒在减轻与口服阿莫西林相关的胃部不适方面更具优势。益生菌的代谢产物减少了肠道病原体、炎症和氧化,这表明果胶阿莫西林颗粒剂能有效保护胃肠道。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Gastroprotective Efficacy of Prebiotic-based Oral Formulation of Amoxicillin

Purpose

Amoxicillin's side effects are due to its propensity to disturb gut flora. Prebiotics can aid in reversing the dysbiosis caused by antibiotics by promoting the growth of various indigenous gut flora. The present investigation aims to determine the prebiotic potential of common binders (starch, gelatin, pectin, and guar gum) against L. acidophilus. The further objective is to explore the potential biological advantages of amoxicillin therapy when prepared with potential prebiotic excipients.

Methods

In the current investigation, prebiotic-based amoxicillin granules were prepared by wet granulation method with 81.5 ± 3.26% yield. To ensure their therapeutic outcomes, prepared granules were evaluated based on drug release profile, drug degradation, prebiotic potential, in vitro antimicrobial activity, antioxidant activity, anti-inflammatory activity, and anti-diarrhoeal potential.

Results

After 24, 36, 48 and 60 h of incubation of L. acidophilus in different base materials, it was found that the growth of L. acidophilus was more in pectin, among other binders. Formulated granules showed better intestinal stability and sustained release profile (~ 60% release in 4 h). FTIR, DSC and XRD analyses revealed minimal interaction between the drug and the selected excipients. Granules were found to have superior S. aureus and P. aeruginosa inhibition potential compared with the pure drug and starch formulations. Also, the highest antioxidant activity was observed in the Pectin granules compared to starch granules and the pure drug. IL-6, IL1β, and TNF-α levels of the pectin-treated group show better anti-inflammatory properties than starch formulations and pure drugs. The anti-diarrhoeal effect of pectin was found to be better because it supports the growth of probiotics.

Conclusion

In this study, pectin-based amoxicillin granules were superior in mitigating the gastric distress associated with oral amoxicillin administration. The metabolites of probiotics reduced gut pathogens, inflammation, and oxidation, suggesting that the formulated pectin-amoxicillin granules effectively provide gastroprotection.

Graphical Abstract

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Journal of Pharmaceutical Innovation
Journal of Pharmaceutical Innovation PHARMACOLOGY & PHARMACY-
CiteScore
3.70
自引率
3.80%
发文量
90
审稿时长
>12 weeks
期刊介绍: The Journal of Pharmaceutical Innovation (JPI), is an international, multidisciplinary peer-reviewed scientific journal dedicated to publishing high quality papers emphasizing innovative research and applied technologies within the pharmaceutical and biotechnology industries. JPI''s goal is to be the premier communication vehicle for the critical body of knowledge that is needed for scientific evolution and technical innovation, from R&D to market. Topics will fall under the following categories: Materials science, Product design, Process design, optimization, automation and control, Facilities; Information management, Regulatory policy and strategy, Supply chain developments , Education and professional development, Journal of Pharmaceutical Innovation publishes four issues a year.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信